Assyro AI

FDA Orange Book · active-ingredient family

Benzoyl peroxide

Benzoyl peroxide is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:EPSOLAY · NDA 214510

1

Brand (NDA)

0

Generics (ANDA)

14

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream

ProductApplicantApplicationTEApproved
EPSOLAYRLDMAYNE PHARMANDA 214510Apr 22, 2022

Listed patents (14)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12350382Feb 03, 2028in 1 yr 8 mo
Product
12156946Feb 03, 2028in 1 yr 8 mo
Product
9868103Aug 08, 2028in 2 yr 2 mo
ProductU-3356
9687465Nov 27, 2032in 6 yr 6 mo
ProductU-3356
10945987Feb 19, 2040in 13 yr 10 mo
U-3356
11877997Feb 19, 2040in 13 yr 10 mo
U-3356
10933046Feb 19, 2040in 13 yr 10 mo
ProductU-3357
11541026Feb 19, 2040in 13 yr 10 mo
U-3356
11986456Feb 19, 2040in 13 yr 10 mo
U-3947
11865100Feb 19, 2040in 13 yr 10 mo
U-3357
11426378Aug 18, 2040in 14 yr 4 mo
U-3356
12295935Dec 27, 2040in 14 yr 9 mo
U-3356
11628155Dec 27, 2040in 14 yr 9 mo
U-3356
12257348May 23, 2041in 15 yr 2 mo
ProductU-3947

Benzoyl peroxide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.